Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis drops long-acting version of Vanda Pharmaceuticals drug
Bizjournals.com
Friday, October 12, 2012 - 11:13am
tags:
Novartis, Vanda, Fanapt, schizophrenia
Is a VIVUS Buyout Still on the Table? And if So, by Whom?
Motley Fool
Friday, October 12, 2012 - 11:02am
tags:
Vivus, M&A, Bristol-Myers Squibb, Merck, JNJ, Arena Pharmaceuticals
Genzyme presents second Phase III study of once-daily AUBAGIO
Yahoo/Fly on the Wall
Friday, October 12, 2012 - 11:00am
tags:
Genzyme, Aubagio, MS, multiple sclerosis
A Fresh Look At KERX; High Odds For Zerenex Phase III Success
Yahoo/Reuters
Friday, October 12, 2012 - 10:59am
tags:
Keryx, Zerenex, kidney disease
3 Things to Watch with Abbott's Upcoming Earnings
Motley Fool
Friday, October 12, 2012 - 10:58am
tags:
Abbott Labs, earnings
Pfizer Appeals Court’s Order for CEO to Testify at Trial
Bloomberg
Friday, October 12, 2012 - 10:57am
tags:
Pfizer, Pharma CEOs, Ian Read, Chantix
Here's Why Nektar Therapeutics's Latest Report Might Worry You
Motley Fool
Thursday, October 11, 2012 - 5:48pm
tags:
Nektar
Good News For Biogen's $7 Billion Rituxin: Copying Drugs Bio Drugs Ain't Easy
Forbes
Thursday, October 11, 2012 - 5:45pm
tags:
Biogen Idec, Rituxan, Genentech
3 Biotechs Facing the Firing Squad Next Week
Motley Fool
Thursday, October 11, 2012 - 5:42pm
tags:
Gattex, NPS Pharmaceuticals, lomitapide, Aegerion, Sanofi, Isis Pharmaceuticals, mipomersen
Independent Expert Likes Vertex CF Data
Forbes
Thursday, October 11, 2012 - 5:37pm
tags:
Vertex Pharmaceuticals, cystic fibrosis
Forest Labs Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Thursday, October 11, 2012 - 11:42am
tags:
Forest Labs, earnings
AEterna Zentaris' Pipeline Giving It A Lift As A Bottom Bounce Trade
Seeking Alpha
Thursday, October 11, 2012 - 11:42am
tags:
Aeterna Zentaris, perifosine
Bristol Myers' Competition Causes Increased Risk
Seeking Alpha
Thursday, October 11, 2012 - 11:39am
tags:
Bristol-Myers Squibb, Pfizer, Sanofi, Eli Lilly, AstraZeneca
Will GlaxoSmithKline's transparency pledge force pharma rivals to open up?
Fierce Biotech
Thursday, October 11, 2012 - 10:49am
tags:
GSK, clinical trials
Is Alzheimer's Research the Next Big Thing in Biotech?
Motley Fool
Thursday, October 11, 2012 - 10:47am
tags:
Alzheimer's disease, Eisai, Forest Labs, JNJ, Pfizer, Eli Lilly, Roche
Johnson & Johnson Slipping Ahead Of Q3 Earnings; Shares At Key Support Level
Seeking Alpha
Thursday, October 11, 2012 - 10:40am
tags:
earnings, JNJ
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thursday, October 11, 2012 - 10:39am
tags:
vortioxetine, Vectura, tofacitinib, Takeda, T-DM1, Sanofi, Roche, REGN727, Regeneron, Reata, QVA149, Pfizer, Odanacatib, Novartis, MorphoSys, Merck, macitentan, Lundbeck, Immunogen, GSK, GS-7977, Gilead, gantenerumab, Eliquis, darapladib, Bristol-Myers Squibb, Biogen Idec, BG-12, Bayer, Bardoxolone, Anacetrapib, Alpharadin, Algeta, Actelion, AbbVie
NPS Pharma: Gattex FDA Panel Preview
TheStreet.com
Thursday, October 11, 2012 - 10:24am
tags:
Gattex, advisory panels, NPS Pharmaceuticals, FDA
Teva to Test MS Pill Laquinimod in Combination Therapy
Bloomberg
Thursday, October 11, 2012 - 10:21am
tags:
Teva, MS, laquinimod, multiple sclerosis, Copaxone
Roche teams up with VC in hearing loss project
Pharma Times, UK
Thursday, October 11, 2012 - 9:32am
tags:
Roche, hearing loss, venture capital

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.